THC Biomed Intl Ltd.
THC
CNSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -567.15% | 39.73% | -1,351.76% | 5.37% | 90.12% |
| Total Depreciation and Amortization | 140.99% | -14.72% | -8.81% | 54.07% | -69.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.21% | -73.29% | 118.01% | -39.02% | -162.30% |
| Change in Net Operating Assets | 1,348.72% | 689.45% | 43.70% | -15.26% | -72.57% |
| Cash from Operations | 107.49% | 75.40% | 66.96% | -154.46% | 3.01% |
| Capital Expenditure | 99.76% | 76.50% | 99.52% | -74.75% | -1,076.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1,350.00% | 269.23% | -5,983.33% | -- |
| Cash from Investing | -102.91% | 55.73% | 123.76% | 33.24% | 17,486.32% |
| Total Debt Issued | 143.00% | -19.48% | -- | 728.24% | -- |
| Total Debt Repaid | 93.20% | -12.06% | 71.90% | -7,321.47% | -984.75% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 110.81% | -47.47% | -109.74% | -421.47% | -2,204.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.70% | 72.51% | -212.19% | -604.73% | 235.89% |